HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy

Listen to expert insights on key concepts in HABP/VABP and gram-negative resistance management, including epidemiology, risk factors, burden of disease, diagnostics, and optimizing treatment regimens to minimize the time to effective therapy.